VBI Vaccines Company Description
VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease.
It offers hepatitis B (HBV) vaccine under the PreHevbrio, PreHevbri, and Sci-B-Vac brand names. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma cancer vaccine immunotherapeutic candidate; VBI-1501, a prophylactic cytomegalovirus vaccine candidate; and VBI-2501 to treat Zika virus.
In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905.
The company has collaboration and license agreements with Brii Biosciences Limited, the National Research Council of Canada, and Coalition for Epidemic Preparedness Innovations.
The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016.
VBI Vaccines Inc. is based in Cambridge, Massachusetts.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 138 |
| CEO | Jeffery Baxter |
Contact Details
Address: 160 Second Street Cambridge, British Columbia 02142 United States | |
| Phone | 617 830 3031 |
| Website | vbivaccines.com |
Stock Details
| Ticker Symbol | VBIVQ |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jeffery R. Baxter FCMA | President, Chief Executive Officer and Director |
| Nell Beattie | Chief Financial Officer, Head of Corporate Development and Director |
| Dr. David Evander Anderson Ph.D. | Chief Scientific Officer |
| Dr. Francisco Diaz-Mitoma FRCPC, M.D., Ph.D. | Chief Medical Officer |
| Nicole Anderson | Director of Corporate Communications and Investor Relations |
| Athena Kartsaklis | Senior Vice President of Finance, Chief Compliance Officer and Principal Financial Officer |
| Avi Mazaltov | Global Head of Manufacturing and GM of SciVac |
| Misha Nossov | Senior Vice President of Global Commercial Supply Strategy and Head of Europe |
| T. Adam Buckley B.Sc., MBA | Senior Vice President of Business Development |
| John Robert Dillman | Chief Commercial Officer |